GlassScriptPhysician profile
Catherine Le
NPI 1821446907
$1,440.78
in general payments reported to CMS, 2019-2025
15 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $324 · 2023: $516 · 2024: $286 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $364.79 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genzyme Corporation | $125.00 | 2022 | |
| Abbvie INC. | $115.48 | 2025 | |
| Lilly USA, LLC | $115.48 | 2025 | Zepbound |
| Gilead Sciences, INC. | $114.28 | 2023 | Epclusa |
| Novo Nordisk INC | $109.01 | 2024 | |
| Calliditas Therapeutics US INC. | $108.53 | 2022 | |
| Melinta Therapeutics, LLC | $101.66 | 2023 | Rezzayo |
| Glaxosmithkline, LLC. | $97.50 | 2023 | Shingrix |
| Alexion Pharmaceuticals, INC. | $89.98 | 2022 | |
| Acera Surgical, INC. | $34.19 | 2025 | Restrata Wound Matrix |
| Ferring Pharmaceuticals INC. | $18.71 | 2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $16.83 | 2025 | |
| Bioventus LLC | $15.26 | 2025 | Exogen Ultrasound Bone Healing System |
| Janssen Pharmaceuticals, INC | $14.08 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.